The breast cancer cell lines T47D and MDA-MB-361 and the bladder cancer cell line RT112 were selected based on immunohistochemistry staining for HER2 on tumor xenografts using the HercepTestTM IHC kit (data not shown). This evidence concerns the gene ERBB2 and urinary bladder carcinoma.